Finance Home - My Yahoo - Yahoo! - Help

Thursday, November 26, 2009, 8:48AM ET - U.S. Markets Closed for Thanksgiving Day. Dow  0.29% Nasdaq  0.32%

XOMA Ltd. (XOMA)

On Nov 25: 0.728   0.002 (0.27%)

MORE ON XOMA

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Thu, Nov 19, 2009 • XOMA LTD /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra EDGAR Online (Thu, Nov 19) • XOMA Receives NASDAQ Determination Letter GlobeNewswire (Thu, Nov 19) Wed, Nov 18, 2009 • Coverage initiated on XOMA Limited by Canaccord Adams Briefing.com (Wed, Nov 18) Tue, Nov 17, 2009 • XOMA Appoints Jim Neal Vice President of Business Development GlobeNewswire (Tue, Nov 17) Fri, Nov 13, 2009 • Biotech Stock Mailbag: Cardium Therapeutics at TheStreet.com (Fri, Nov 13) • XOMA LTD /DE/ Financials EDGAR Online Financials (Fri, Nov 13) Thu, Nov 12, 2009 • XOMA 052 Selected as a Top Ten Project to Watch GlobeNewswire (Thu, Nov 12) Wed, Nov 11, 2009 • XOMA Announces Presentation at Lazard Healthcare Conference on November 18 GlobeNewswire (Wed, Nov 11) Mon, Nov 9, 2009 • XOMA LTD /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online (Mon, Nov 9) • Doc Offers Top Hep C Drug Picks: BioBuzz at TheStreet.com (Mon, Nov 9) • XOMA Ltd. Q3 2009 Earnings Call Transcript at Seeking Alpha (Mon, Nov 9) • Xoma Waffles on Timing of Drug Partnership: BioBuzz at TheStreet.com (Mon, Nov 9) • XOMA Reports 2009 Third Quarter Financial Results GlobeNewswire (Mon, Nov 9) • Q3 2009 XOMA Ltd. Earnings Release - Before Market Open CCBN (Mon, Nov 9) Fri, Nov 6, 2009 • Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For Investors Wall Street Transcript (Fri, Nov 6) • XOMA Expands Development Strategy for XOMA 052 to Include Cardiovascular Diseases GlobeNewswire (Fri, Nov 6) Wed, Nov 4, 2009 • XOMA Granted First European Patent Covering XOMA 052 GlobeNewswire (Wed, Nov 4) • Phase 2 Trial of XOMA 052 to be Initiated in Type 1 Diabetes Patients GlobeNewswire (Wed, Nov 4) Tue, Nov 3, 2009 • XOMA to Announce Third Quarter 2009 Financial Results and Host Conference Call on November 9 GlobeNewswire (Tue, Nov 3) • Vivus promotes COO to president at bizjournals.com (Tue, Nov 3) Older Headlines - Download Recent Headlines View headlines from: Tue, Nov 3, 2009Tue, Oct 27, 2009Tue, Oct 20, 2009Tue, Oct 13, 2009Tue, Oct 6, 2009Tue, Sep 29, 2009Tue, Sep 22, 2009Tue, Sep 15, 2009Tue, Sep 8, 2009Tue, Sep 1, 2009 Add XOMA News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage